Workforce reductions can often lead to short-term operational disruptions and may impact productivity. However, they can also be a sign of cost-cutting measures, which could potentially improve the company's financial health in the long run. The lack of details provided by Sana Biotechnology makes it difficult to predict the exact impact on its stock.